Waters Launches Progenesis QI Version 2.0 for Small Molecule Data Analysis at IMSC 2014
Next Generation Software Offers Enhanced Control and Function, with Pathway Mapping, Process Automation, and Improved Access to Compound Databases
GENEVA–(BUSINESS WIRE)–Aug. 25, 2014– Waters Corporation (NYSE: WAT) today introduced Progenesis® QIVersion 2.0, the next generation of liquid chromatography-mass spectrometry (LC-MS) software for small molecule ‘omics data analysis, at the 20th International Mass Spectrometry Conference in Geneva, Switzerland.
Today’s announcement complements the June introduction of Progenesis QI for proteomics Version 2.0 for large molecule ‘omics data analysis. Both Progenesis QI and Progenesis QI for proteomics software take LC-MS data analysis to new levels of speed and sophistication, enabling users to rapidly quantify and identify the significantly changing small molecule, lipid compounds, and proteins in samples.
The new features of Progenesis QI Version 2.0 include Pathway Mapping, which facilitates the process of placing discoveries into a biological context, extracting maximum value from ‘omics data; Workflow Automation, which enables the software to move through multiple processing stages without user intervention, thus saving valuable time and allowing for overnight and weekend processing; Improved access to compound databases, increasing the chance of successful compound identification; and seamless integration with the extended statistics functionality in EZInfo 3.0, with two-way dataflow to allow for flexible data mining through a single, menu-driven command.
“Discovery is nothing without understanding,” said Dr. Rohit Khanna, Vice President of Informatics and Worldwide Marketing for the Waters Division. “The new version of Progenesis QI features interface improvements that make working with the software even faster and more intuitive than before, giving users more confidence in their research and a deeper understanding of the results.”
Progenesis QI Version 2.0 provides an easy-to-learn, intuitive workflow that is flexible and based on how researchers function. It has a highly-visual interface. The expanded functionality has broad applications across a wide variety of areas including pharmaceutical, health sciences, food, environmental and chemical research.
For more information about Progenesis QI Version 2.0 software, visit http://www.nonlinear.com/progenesis/qi/.
About Progenesis QI Software
Waters introduced Progenesis QI and Progenesis QI for proteomics in April 2014 at the Analytica conference inMunich, Germany, following the company’s acquisition of Nonlinear Dynamics Ltd., the world leader in ‘omics data analysis software.
In June 2014, Waters expanded its suite of focused informatics packages with the release of Progenesis QI for proteomics Version 2.0.
Progenesis QI software enables researchers to accurately quantify and identify compounds and proteins with unique methods to analyze and visualize LC-MS data. Supporting all common LC-MS data formats with intuitive guided workflows, Progenesis QI software allows customers to rapidly, objectively and reliably discover compounds and proteins of interest in their valuable samples. With new features including pathway mapping, process automation, and improved access to compound databases, Progenesis QI Version 2.0 offers enhanced control and function.
About Waters Corporation (www.waters.com)
For more than 50 years, Waters Corporation has created business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality, consumer products and high-value added chemicals worldwide.
Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.
With revenue of $1.9 billion in 2013, Waters is driving scientific discovery and operational excellence for customers worldwide.